Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Novel Therapeutic Options for Small Cell Lung Cancer
Stefania Canova, Benedetta Trevisan, Maria Ida Abbate, et al.
Current Oncology Reports (2023) Vol. 25, Iss. 11, pp. 1277-1294
Open Access | Times Cited: 12

Showing 12 citing articles:

Treatment-related Adverse Events, Including Fatal Toxicities, in Patients With Extensive-stage Small-cell Lung Cancer Receiving Adjuvant Programmed Cell Death 1/Programmed Cell Death Ligand 1 Inhibitors: A Meta-analysis and Trial Sequential Analysis of Randomized Controlled Trials
Francisco Cézar Aquino de Moraes, Artur de Oliveira Macena Lôbo, Vitor Kendi Tsuchiya Sano, et al.
Clinical Oncology (2024) Vol. 36, Iss. 10, pp. e408-e419
Closed Access | Times Cited: 5
Aurora kinase A promotes trained immunity via regulation of endogenous S-adenosylmethionine metabolism
Mengyun Li, Huan Jin, Yongxiang Liu, et al.
(2025)
Open Access
Aurora kinase A promotes trained immunity via regulation of endogenous S-adenosylmethionine metabolism
Mengyun Li, Huan Jin, Yongxiang Liu, et al.
(2025)
Open Access
Adoptive cell therapies in thoracic malignancies: a comprehensive review
Yago Garitaonaindía, M. Martínez‐Cutillas, Maria Uribarren, et al.
Clinical & Translational Oncology (2025)
Closed Access
Multiomics-Based Deep Learning Prediction of Prognosis and Therapeutic Response in Patients With Extensive-Stage Small Cell Lung Cancer Receiving Chemoimmunotherapy: A Retrospective Cohort Study
Fang Nie, Xiufeng Pei, Jiahui Du, et al.
International Journal of General Medicine (2025) Vol. Volume 18, pp. 981-996
Open Access
Efficacy and safety of different immunotherapies combined with chemotherapy as first-line therapy in patients with small cell lung cancer: a network meta-analysis
Siyao Gong, Qian Li, Xin Yu, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 2
Quantitative Membrane Proteomics for Discovery of Actionable Drug Targets at the Surface of RAS-Driven Human Cancer Cells
Xiaoying Ye
Methods in molecular biology (2024), pp. 27-46
Closed Access
Predictive Signatures for Responses to Checkpoint Blockade in Small-Cell Lung Cancer in Second-Line Therapy Do Not Predict Responses in First-Line Patients
Jeffrey C. Thompson, Caitlin M. Tilsed, Christiana Davis, et al.
Cancers (2024) Vol. 16, Iss. 16, pp. 2795-2795
Open Access
[ORY-1001 inhibits glioblastoma cell growth by downregulating the Notch/HES1 pathway
Huan Yang, Yi Xiang, Tingting Tan, et al.
PubMed (2024) Vol. 44, Iss. 8, pp. 1620-1630
Closed Access
Editorial: Molecular targets in oncological and hematological disease management: innovations in precision medicine
Adrian Bogdan Țigu, Gregory Wiedman, Stefan Eugen Szedlacsek
Frontiers in Pharmacology (2024) Vol. 15
Open Access
Differential KEAP1/NRF2 mediated signaling widens the therapeutic window of redox-targeting drugs in SCLC therapy
Jana Samarin, Hana Nůsková, Piotr Fabrowski, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access
Aurora kinase A promotes trained immunity via regulation of endogenous S-adenosylmethionine metabolism
Mengyun Li, Shengkan Jin, Yongxiang Liu, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access
Page 1

Scroll to top